Sionna Therapeutics, Inc.
SION
10 insider filings · Latest: May 7, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 11 11:14 PM | Peter A. ThompsonDirector | Sale | 184,639 | $46.22 | $8.5M | 2,671,822(I) | View → |
| May 8, 2026 | May 11 11:14 PM | Peter A. ThompsonDirector | Sale | 59,767 | $44.58 | $2.7M | 2,856,461(I) | View → |
| May 7, 2026 | May 11 11:14 PM | Peter A. ThompsonDirector | Sale | 48,546 | $44.61 | $2.2M | 2,916,228(I) | View → |
| May 11, 2026 | May 11 10:58 PM | ORBIMED ADVISORS LLCDirector | Sale | 184,639 | $46.22 | $8.5M | 2,671,822(I) | View → |
| May 8, 2026 | May 11 10:58 PM | ORBIMED ADVISORS LLCDirector | Sale | 59,767 | $44.58 | $2.7M | 2,856,461(I) | View → |
| May 7, 2026 | May 11 10:58 PM | ORBIMED ADVISORS LLCDirector | Sale | 48,546 | $44.61 | $2.2M | 2,916,228(I) | View → |
| Apr 18, 2026 | Apr 22 12:42 AM | Peter A. ThompsonDirector | Sale | 2,948 | $44.52 | $131.2K | 2,964,774(I) | View → |
| Apr 17, 2026 | Apr 22 12:42 AM | Peter A. ThompsonDirector | Sale | 52,397 | $44.68 | $2.3M | 2,967,722(I) | View → |
| Apr 18, 2026 | Apr 22 12:40 AM | ORBIMED ADVISORS LLCDirector | Sale | 2,948 | $44.52 | $131.2K | 2,964,774(I) | View → |
| Apr 17, 2026 | Apr 22 12:40 AM | ORBIMED ADVISORS LLCDirector | Sale | 52,397 | $44.68 | $2.3M | 2,967,722(I) | View → |
| Apr 16, 2026 | Apr 16 11:15 PM | Peter A. ThompsonDirector | Sale | 226,906 | $45.34 | $10.3M | 3,020,119(I) | View → |
| Apr 15, 2026 | Apr 16 11:15 PM | Peter A. ThompsonDirector | Sale | 235,863 | $44.64 | $10.5M | 3,247,025(I) | View → |
| Apr 14, 2026 | Apr 16 11:15 PM | Peter A. ThompsonDirector | Sale | 47,814 | $44.51 | $2.1M | 3,482,888(I) | View → |
| Apr 16, 2026 | Apr 16 11:03 PM | ORBIMED ADVISORS LLCDirector | Sale | 226,906 | $45.34 | $10.3M | 3,020,119(I) | View → |
| Apr 15, 2026 | Apr 16 11:03 PM | ORBIMED ADVISORS LLCDirector | Sale | 235,863 | $44.64 | $10.5M | 3,247,025(I) | View → |
| Apr 14, 2026 | Apr 16 11:03 PM | ORBIMED ADVISORS LLCDirector | Sale | 47,814 | $44.51 | $2.1M | 3,482,888(I) | View → |
| Mar 5, 2026 | Mar 6 11:56 PM | Jennifer FitzpatrickChief Legal Officer | Sale | 10,250 | $33.86 | $347.0K | 0(D) | View → |
| Mar 5, 2026 | Mar 5 9:28 PM | JENNIFER FITZPATRICK | Proposed Sale | 10,250 | $34.57 | $354.3K | — | View → |
| Feb 3, 2026 | Feb 5 12:43 AM | Peter A. ThompsonDirector | Sale | 29,063 | $44.58 | $1.3M | 3,530,702(I) | View → |
| Feb 2, 2026 | Feb 5 12:43 AM | Peter A. ThompsonDirector | Sale | 1,890 | $44.57 | $84.2K | 3,559,765(I) | View → |
Page 1 of 5
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Mar 6 11:56 PM | Jennifer FitzpatrickChief Legal Officer | Option Exercise | 10,250 | $6.11 | 50,935(D) | View → |